These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9914470)

  • 1. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells.
    Regev R; Assaraf YG; Eytan GD
    Eur J Biochem; 1999 Jan; 259(1-2):18-24. PubMed ID: 9914470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD; Sharom FJ
    Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
    Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
    Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.
    Orlowski S; Mir LM; Belehradek J; Garrigos M
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):515-22. PubMed ID: 8713080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
    Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
    Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes.
    Park S; Majd S
    PLoS One; 2018; 13(6):e0199279. PubMed ID: 29912971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.
    Sharom FJ; Yu X; Chu JW; Doige CA
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):381-90. PubMed ID: 7772017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.
    Doige CA; Yu X; Sharom FJ
    Biochim Biophys Acta; 1992 Aug; 1109(2):149-60. PubMed ID: 1355666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
    Borgnia MJ; Eytan GD; Assaraf YG
    J Biol Chem; 1996 Feb; 271(6):3163-71. PubMed ID: 8621716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-stimulated ATPase activity of the human P-glycoprotein.
    Scarborough GA
    J Bioenerg Biomembr; 1995 Feb; 27(1):37-41. PubMed ID: 7629050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 2001 Jun; 40(23):6937-47. PubMed ID: 11389609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
    Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
    Garrigos M; Mir LM; Orlowski S
    Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
    Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pluronic P85 on ATPase activity of drug efflux transporters.
    Batrakova EV; Li S; Li Y; Alakhov VY; Kabanov AV
    Pharm Res; 2004 Dec; 21(12):2226-33. PubMed ID: 15648254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form.
    Rebbeor JF; Senior AE
    Biochim Biophys Acta; 1998 Feb; 1369(1):85-93. PubMed ID: 9528676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flip-flop of doxorubicin across erythrocyte and lipid membranes.
    Regev R; Eytan GD
    Biochem Pharmacol; 1997 Nov; 54(10):1151-8. PubMed ID: 9464458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of a tryptophan-less P-glycoprotein: a tool for tryptophan insertion and fluorescence spectroscopy.
    Kwan T; Loughrey H; Brault M; Gruenheid S; Urbatsch IL; Senior AE; Gros P
    Mol Pharmacol; 2000 Jul; 58(1):37-47. PubMed ID: 10860925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.